Your search for major depressive disorder returned 394 results

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder

Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.

Deep learning, multidiagnostic model shows high accuracy before clinical examination

Treatment-resistant depression episodes tied to more psychiatric comorbid conditions, health care utilization, self-harm, and all-cause mortality

Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.

Being married, having a confidant associated with better mental health with COPD

Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.

Researchers sought to develop a patient-centered COS for QOL evaluation in clinical practice for adults with drug-resistant epilepsy.

Researchers measured associations between trauma and child psychiatric disorders in a birth cohort in Brazil.

A team of investigators evaluated the prevalence of noncancer-related pain conditions among adult individuals with attention-deficit/hyperactivity disorder.

Danny Eckert, PhD, a researcher on human sleep and respiratory physiology, explains the potential bidirectional relationship and the clinical complications of COMISA, comorbid insomnia and sleep apnea.

As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.

Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity

Cognitive impairment in individuals with major depressive disorder should be treated as a primary problem.

The FDA has cleared Nexstim’s NBT system for the treatment of major depressive disorder.

Investigators sought to determine the frequency of major depressive disorder in patients in epilepsy clinics.

Changes to brain structure indicate possible underlying connection to idiopathic major depressive disorder.

Screening recommended for those aged 12 to 18, however there is insufficient evidence to assess for children aged 11 and younger.

Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).

Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.

Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.

Mirtazapine is a central alpha-2 antagonist currently FDA-approved for the treatment of major depressive disorder.

For patients with major depressive disorde, relapse is associated with brain cortical changes over two years.

Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.

Migraine with active headache may predict other painful physical symptoms in patients with major depressive disorder.

Researchers suggest that improvement in cognitive function should be a goal for major depressive disorder because their data showed little improvement in the cognitive abilities of patients with major depression after treatment with psychological interventions.

The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.